Yihang Pan

5.0k total citations · 5 hit papers
86 papers, 3.5k citations indexed

About

Yihang Pan is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yihang Pan has authored 86 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 22 papers in Oncology and 10 papers in Surgery. Recurrent topics in Yihang Pan's work include Epigenetics and DNA Methylation (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Cancer therapeutics and mechanisms (6 papers). Yihang Pan is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Cancer therapeutics and mechanisms (6 papers). Yihang Pan collaborates with scholars based in China, United States and Hong Kong. Yihang Pan's co-authors include Yun Chen, Zhizhuang Joe Zhao, Yao Guo, Leli Zeng, Yulong He, Zhe‐Sheng Chen, Zi‐Ning Lei, Qiu‐Xu Teng, Ningning Li and Shuo Fang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Yihang Pan

83 papers receiving 3.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure analysis of the receptor binding of 2019-nCoV

2020 563 citations Yihang Pan et al. profile →
Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion

2018 395 citations Yubin Huang, Zhen Xu et al. Nature Neuroscience profile →
An Enzyme‐Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis‐Based Synergistic Cancer Therapy

2022 323 citations Yuzhi Xu, Si‐Yang Liu et al. Advanced Materials profile →
Understanding and targeting resistance mechanisms in cancer

2023 177 citations Zi‐Ning Lei, Tian Qin et al. SHILAP Revista de lepidopterología profile →
Signaling pathways and therapeutic interventions in gastric cancer

2022 167 citations Zi‐Ning Lei, Qiu‐Xu Teng et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yihang Pan China	27	1.5k	693	548	446	433	86	3.5k
Jing Xu China	34	1.7k 1.2×	535 0.8×	383 0.7×	373 0.8×	410 0.9×	152	4.0k
Weiqi Hong China	22	1.7k 1.2×	561 0.8×	739 1.3×	383 0.9×	544 1.3×	43	3.4k
Paolo Fagone Italy	36	1.5k 1.0×	508 0.7×	441 0.8×	300 0.7×	1.1k 2.6×	121	3.7k
Xiaoyi Yang China	29	1.2k 0.8×	501 0.7×	148 0.3×	284 0.6×	341 0.8×	99	2.6k
Wei Shi China	24	1.1k 0.7×	814 1.2×	191 0.3×	361 0.8×	683 1.6×	90	3.0k
Xin Yu China	30	1.1k 0.8×	744 1.1×	129 0.2×	575 1.3×	218 0.5×	147	3.1k
Ni Wang China	34	1.5k 1.1×	379 0.5×	150 0.3×	477 1.1×	230 0.5×	181	3.5k
Marina Di Domenico Italy	38	2.5k 1.7×	1.2k 1.7×	224 0.4×	546 1.2×	347 0.8×	138	5.4k
Jessica Foley United States	17	1.2k 0.8×	1.5k 2.1×	464 0.8×	534 1.2×	143 0.3×	39	3.0k
Youngmi Kim South Korea	36	2.4k 1.6×	838 1.2×	130 0.2×	1.0k 2.3×	736 1.7×	146	4.8k

Countries citing papers authored by Yihang Pan

Since Specialization

Citations

This map shows the geographic impact of Yihang Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yihang Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yihang Pan more than expected).

Fields of papers citing papers by Yihang Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yihang Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yihang Pan. The network helps show where Yihang Pan may publish in the future.

Co-authorship network of co-authors of Yihang Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Yihang Pan. A scholar is included among the top collaborators of Yihang Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yihang Pan. Yihang Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liang, Jinzhe, et al.. (2024). Recent advances in the development of metallodrugs for cancer chemoimmunotherapy. Coordination Chemistry Reviews. 526. 216319–216319. 8 indexed citations

He, Qiangsheng, et al.. (2024). Alterations in gut microbiota and bile acids by proton‐pump inhibitor use and possible mediating effects on elevated glucose levels and insulin resistance. The FASEB Journal. 38(6). e23541–e23541. 3 indexed citations

Feng, Tao, Johannes Karges, Jinchao Shen, et al.. (2023). Exosome camouflaged coordination-assembled Iridium(III) photosensitizers for apoptosis-autophagy-ferroptosis induced combination therapy against melanoma. Biomaterials. 301. 122212–122212. 54 indexed citations

Xu, Shengshan, Hongyu Chu, Shuo Fang, et al.. (2023). Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Frontiers in Immunology. 14. 1155182–1155182. 16 indexed citations

He, Qiangsheng, Xiwen Qin, Yuanyuan Yu, et al.. (2023). Confounded association between proton pump inhibitor use and risk of biliary tract cancer: Result from three cohorts. International Journal of Cancer. 153(5). 942–949. 1 indexed citations

Wang, Siqi, Yuchen Jiang, Zi‐Ning Lei, et al.. (2023). Targeting GSTP1 as Therapeutic Strategy against Lung Adenocarcinoma Stemness and Resistance to Tyrosine Kinase Inhibitors. Advanced Science. 10(7). e2205262–e2205262. 26 indexed citations

Lei, Zi‐Ning, Tian Qin, Qiu‐Xu Teng, et al.. (2023). Understanding and targeting resistance mechanisms in cancer. SHILAP Revista de lepidopterología. 4(3). e265–e265. 177 indexed citations breakdown →

Xu, Yuzhi, Si‐Yang Liu, Leli Zeng, et al.. (2022). An Enzyme‐Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis‐Based Synergistic Cancer Therapy. Advanced Materials. 34(43). e2204733–e2204733. 323 indexed citations breakdown →

Lei, Zi‐Ning, Qiu‐Xu Teng, Tian Qin, et al.. (2022). Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduction and Targeted Therapy. 7(1). 358–358. 167 indexed citations breakdown →

10.

Liu, Minling, et al.. (2022). Value of Cytokine Expression in Early Diagnosis and Prognosis of Tumor Metastasis. Journal of Oncology. 2022. 1–9. 2 indexed citations

11.

Tang, Yancheng, Liming Wang, Tao Yi, et al.. (2021). Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy. Acta Pharmaceutica Sinica B. 11(12). 3966–3982. 44 indexed citations

12.

Wu, Zhuo‐Xun, Yuqi Yang, Jing‐Quan Wang, et al.. (2021). Overexpression of human ATP-binding cassette transporter ABCG2 contributes to reducing the cytotoxicity of GSK1070916 in cancer cells. Biomedicine & Pharmacotherapy. 136. 111223–111223. 17 indexed citations

13.

Li, Jia, Leli Zeng, Zheng Wang, et al.. (2021). Cycloruthenated Self‐Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers. Advanced Materials. 34(1). e2100245–e2100245. 46 indexed citations

14.

Xia, Bin, Qiangsheng He, Yihang Pan, et al.. (2020). Metabolic syndrome and risk of pancreatic cancer: A population‐based prospective cohort study. International Journal of Cancer. 147(12). 3384–3393. 44 indexed citations

15.

Wang, Jing‐Quan, Qiu‐Xu Teng, Zi‐Ning Lei, et al.. (2020). Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells. Cancers. 12(2). 466–466. 48 indexed citations

16.

Pan, Yihang, Yuan Fang, Meiqi Xin, et al.. (2020). Self-Reported Compliance With Personal Preventive Measures Among Chinese Factory Workers at the Beginning of Work Resumption Following the COVID-19 Outbreak: Cross-Sectional Survey Study. Journal of Medical Internet Research. 22(9). e22457–e22457. 56 indexed citations

17.

Huang, Yubin, Zhen Xu, Shanshan Xiong, et al.. (2020). Author Correction: Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion. Nature Neuroscience. 24(2). 288–288. 6 indexed citations

18.

Pan, Yihang, Meiqi Xin, Changhua Zhang, et al.. (2020). Associations of Mental Health and Personal Preventive Measure Compliance With Exposure to COVID-19 Information During Work Resumption Following the COVID-19 Outbreak in China: Cross-Sectional Survey Study. Journal of Medical Internet Research. 22(10). e22596–e22596. 66 indexed citations

19.

Huang, Yubin, Zhen Xu, Shanshan Xiong, et al.. (2018). Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion. Nature Neuroscience. 21(4). 530–540. 395 indexed citations breakdown →

20.

Liao, Liqiu, Mei Song, Xin Li, et al.. (2017). E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer. Cancer Research. 77(8). 2090–2101. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact